Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4103/psychiatry.IndianJPsychiatry_59_17 http://scihub22266oqcxt.onion/10.4103/psychiatry.IndianJPsychiatry_59_17 C5806324!5806324!29497187     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Indian+J+Psychiatry 2017 ; 59 (4): 451-6 Nephropedia Template TP {{tp|p=29497187|t=2017. Comparison of efficacy of haloperidol and olanzapine in the treatment of delirium |pdf=|usr=}}{{29497187}} gab.com Text Comparison of efficacy of haloperidol and olanzapine in the treatment of delirium JO: Indian J Psychiatry http://www.kidney.de/pget.php?&tw=1&pmid=29497187 #FOAvip Objective:: Till date, typical antipsychotic haloperidol is the treatment of choice for delirium. But, due to higher side effects with haloperidol, newer atypical antipsychotics (e.g., olanzapine) are increasingly being used in the treatment of delirious patients. The aim of the current research was to study the efficacy and tolerability of haloperidol and olanzapine in the treatment of delirium. Materials and Methods:: This was an open-label, randomized controlled study carried out in a tertiary care hospital at Chandigarh, India. A total of 100 patients admitted in medicine, surgery, and orthopedic wards and diagnosed as having delirium on Confusion Assessment Method scale were included in the study. Patients were given either haloperidol (1?4 mg/day either orally or by nasogastric tube) or olanzapine (2.5?10 mg/day either orally or by nasogastric tube). Severity of delirium and pattern of symptom improvement were assessed by Memorial Delirium Assessment Scale (MDAS). Extrapyramidal side effects were assessed by Simpson?Angus Scale. Results:: There was an improvement in delirium severity in both groups with treatment. Mean daily dose of haloperidol and olanzapine used per patient was 2.10 and 5.49 mg, respectively, and the mean duration of treatment in olanzapine group and haloperidol group was 3.57 days and 3.37 days, respectively. There was no significant difference in the mean duration of treatment in both groups. At the end of study period, the MDAS scores in olanzapine and haloperidol groups were 8.43 and 8.00, respectively, and the difference was not significant statistically with P = 0.765. Five patients experienced drug-related mild side effects. Conclusion:: Low-dose haloperidol and olanzapine were equally efficacious and well tolerated in delirium. Twit Text FOAVip Comparison of efficacy of haloperidol and olanzapine in the treatment of delirium ????Indian J Psychiatry http://www.kidney.de/pget.php?&tw=1&pmid=29497187 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29497187 #FOAvip English Wikipedia <ref>{{Cite pmid|29497187}}</ref> Comparison of efficacy of haloperidol and olanzapine in the treatment of delirium #MMPMID29497187 Jain R; Arun P; Sidana A; Sachdev A Indian J Psychiatry 2017[Oct]; 59 (4): 451-6 PMID29497187show ga Objective:: Till date, typical antipsychotic haloperidol is the treatment of choice for delirium. But, due to higher side effects with haloperidol, newer atypical antipsychotics (e.g., olanzapine) are increasingly being used in the treatment of delirious patients. The aim of the current research was to study the efficacy and tolerability of haloperidol and olanzapine in the treatment of delirium. Materials and Methods:: This was an open-label, randomized controlled study carried out in a tertiary care hospital at Chandigarh, India. A total of 100 patients admitted in medicine, surgery, and orthopedic wards and diagnosed as having delirium on Confusion Assessment Method scale were included in the study. Patients were given either haloperidol (1?4 mg/day either orally or by nasogastric tube) or olanzapine (2.5?10 mg/day either orally or by nasogastric tube). Severity of delirium and pattern of symptom improvement were assessed by Memorial Delirium Assessment Scale (MDAS). Extrapyramidal side effects were assessed by Simpson?Angus Scale. Results:: There was an improvement in delirium severity in both groups with treatment. Mean daily dose of haloperidol and olanzapine used per patient was 2.10 and 5.49 mg, respectively, and the mean duration of treatment in olanzapine group and haloperidol group was 3.57 days and 3.37 days, respectively. There was no significant difference in the mean duration of treatment in both groups. At the end of study period, the MDAS scores in olanzapine and haloperidol groups were 8.43 and 8.00, respectively, and the difference was not significant statistically with P = 0.765. Five patients experienced drug-related mild side effects. Conclusion:: Low-dose haloperidol and olanzapine were equally efficacious and well tolerated in delirium. äComparison of efficacy of haloperidol and olanzapine in the treatment (epmc).pdf DeepDyve Pubget Overpricing